Last reviewed · How we verify
Exem Foam Kit (AIR POLYMER-TYPE A)
Exem Foam Kit works by creating a foam that helps to visualize the female reproductive organs during medical imaging procedures.
At a glance
| Generic name | AIR POLYMER-TYPE A |
|---|---|
| Sponsor | Giskit |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
| First approval | 2019 |
Mechanism of action
This foam is created by a small molecule that is designed to be safe and effective for use in medical imaging. When used during endoscopy with hysterosalpingography, the foam helps to improve the clarity of the images obtained, allowing doctors to better diagnose and treat any issues with the reproductive organs.
Approved indications
- Assessing fallopian tube patency
Common side effects
- Pelvic and abdominal pain
- Nausea
- Vasovagal reactions
- Faintness
- Post-procedure spotting
Serious adverse events
- Pelvic inflammatory disease
- Salpingitis
- Tubo-ovarian abscess
Key clinical trials
Patents
| Patent | Expiry | Type |
|---|---|---|
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
| FDA Orange Book | Patents + exclusivity |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Exem Foam Kit CI brief — competitive landscape report
- Exem Foam Kit updates RSS · CI watch RSS
- Giskit portfolio CI